Calendar · pharmadog

Sign In Subscribe

Week of Feb 16, 2026

41

Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval194d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Feb 17, 2026approval194d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Feb 17, 2026approval194d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗

Feb 17, 2026approval194d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

full page →METRONIDAZOLE →fda approvals ↗

Feb 17, 2026approval194d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

full page →METRONIDAZOLE →fda approvals ↗

Feb 17, 2026approval194d agoRELGAABI (GABAPENTIN) — FDA approvalSciegen Pharmaceuticals Inc

Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval194d agoANAGRELIDE HYDROCHLORIDE — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval194d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 17, 2026approval194d agoMEROPENEM — FDA approvalMEROPENEM

Sponsor: QILU. Form: INJECTABLE. Route: INJECTION

full page →MEROPENEM →fda approvals ↗

Feb 18, 2026approval193d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval193d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval193d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval193d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval193d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →tofacitinib citrate ER →fda approvals ↗

Feb 18, 2026approval193d agoARBLI (LOSARTAN POTASSIUM) — FDA approvalLOSARTAN POTASSIUM

Sponsor: SCIENTURE. Form: SUSPENSION. Route: ORAL

full page →LOSARTAN POTASSIUM →fda approvals ↗

Feb 18, 2026approval193d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 18, 2026approval193d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 18, 2026approval193d agoARIPIPRAZOLE — FDA approvalaripiprazole LA

Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →aripiprazole LA →fda approvals ↗

Feb 18, 2026approval193d agoEBANGA (ANSUVIMAB-ZYKL) — FDA approvalansuvimab

Sponsor: RIDGEBACK BIOTHERAPEUTICS. Form: POWDER. Route: IV (INFUSION)

full page →ansuvimab →fda approvals ↗

Feb 18, 2026approval193d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: IPCA LABS LTD. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 19, 2026approval192d agoELREXFIO (ELRANATAMAB) — FDA approvalelranatamab

Sponsor: PFIZER INC. Form: SOLUTION. Route: INJECTION

full page →elranatamab →fda approvals ↗

Feb 19, 2026approval192d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 19, 2026approval192d agoBRIVARACETAM — FDA approvalBRIVARACETAM

Sponsor: MSN. Form: SOLUTION. Route: ORAL

full page →BRIVARACETAM →fda approvals ↗

Feb 19, 2026approval192d agoPOTELIGEO (MOGAMULIZUMAB-KPKC) — FDA approvalmogamulizumab

Sponsor: KYOWA KIRIN. Form: INJECTABLE. Route: INJECTION

full page →mogamulizumab →fda approvals ↗

Feb 19, 2026approval192d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 19, 2026approval192d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 19, 2026approval192d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Feb 19, 2026approval192d agoCALQUENCE (ACALABRUTINIB MALEATE) — FDA approvalCALQUENCE

Sponsor: ASTRAZENECA. Form: TABLET. Route: ORAL

full page →CALQUENCE →fda approvals ↗

Feb 19, 2026approval192d agoCALQUENCE (ACALABRUTINIB) — FDA approvalCALQUENCE

Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL

full page →CALQUENCE →fda approvals ↗

Feb 19, 2026approval192d agoVENCLEXTA (VENETOCLAX) — FDA approvalvenetoclax

Sponsor: ABBVIE. Form: TABLET. Route: ORAL

full page →venetoclax →fda approvals ↗

Feb 20, 2026approval191d agoFAVLYXA (FLUOROURACIL) — FDA approvalEfudex

Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAVENOUS

full page →Efudex →fda approvals ↗

Feb 20, 2026approval191d agoRIVAROXABAN — FDA approvalInvaGen Pharmaceuticals Inc

Sponsor: INVAGEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 20, 2026approval191d agoBYSANTI (MILSAPERIDONE) — FDA approvalVanda Pharmaceuticals Inc.

Sponsor: VANDA PHARMS INC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 20, 2026approval191d agoELUCIREM (GADOPICLENOL) — FDA approval

Sponsor: GUERBET. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 20, 2026approval191d agoVABOMERE (MEROPENEM) — FDA approvalHQ Speciality Pharma

Sponsor: REMPEX. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 20, 2026approval191d agoZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalloncastuximab tesirine

Sponsor: ADC Therapeutics SA. Form: INJECTABLE. Route: INJECTION

full page →loncastuximab tesirine →fda approvals ↗

Feb 20, 2026approval191d agoHEPARIN SODIUM — FDA approvalPharmacia & Upjohn LLC

Sponsor: EMERGE BIOSCIENCE. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 20, 2026approval191d agoHEPARIN SODIUM — FDA approvalPharmacia & Upjohn LLC

Sponsor: EMERGE BIOSCIENCE. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Week of Feb 23, 2026

9

Feb 23, 2026approval188d agoDUPIXENT (DUPILUMAB) — FDA approvaldupilumab

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION

full page →dupilumab →fda approvals ↗

Feb 23, 2026approval

page 367 of 380